Cargando…
Severe hypophosphataemia after intravenous iron administration
Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353490/ https://www.ncbi.nlm.nih.gov/pubmed/28289000 http://dx.doi.org/10.1136/bcr-2016-219160 |
_version_ | 1782515119821946880 |
---|---|
author | Anand, Gurpreet Schmid, Christoph |
author_facet | Anand, Gurpreet Schmid, Christoph |
author_sort | Anand, Gurpreet |
collection | PubMed |
description | Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased awareness of this potential complication among physicians. Patients should be informed of this complication and instructed to report for follow-up if they experience new musculoskeletal symptoms or worsening of tiredness. As severe hypophosphataemia is usually symptomatic, we recommend screening symptomatic patients for this complication. Recognising and treating the possible exacerbating factors, especially vitamin D deficiency, might be a simple measure to mitigate this complication. |
format | Online Article Text |
id | pubmed-5353490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53534902017-03-21 Severe hypophosphataemia after intravenous iron administration Anand, Gurpreet Schmid, Christoph BMJ Case Rep Article Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased awareness of this potential complication among physicians. Patients should be informed of this complication and instructed to report for follow-up if they experience new musculoskeletal symptoms or worsening of tiredness. As severe hypophosphataemia is usually symptomatic, we recommend screening symptomatic patients for this complication. Recognising and treating the possible exacerbating factors, especially vitamin D deficiency, might be a simple measure to mitigate this complication. BMJ Publishing Group 2017-03-10 /pmc/articles/PMC5353490/ /pubmed/28289000 http://dx.doi.org/10.1136/bcr-2016-219160 Text en 2017 BMJ Publishing Group Ltd This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Article Anand, Gurpreet Schmid, Christoph Severe hypophosphataemia after intravenous iron administration |
title | Severe hypophosphataemia after intravenous iron administration |
title_full | Severe hypophosphataemia after intravenous iron administration |
title_fullStr | Severe hypophosphataemia after intravenous iron administration |
title_full_unstemmed | Severe hypophosphataemia after intravenous iron administration |
title_short | Severe hypophosphataemia after intravenous iron administration |
title_sort | severe hypophosphataemia after intravenous iron administration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353490/ https://www.ncbi.nlm.nih.gov/pubmed/28289000 http://dx.doi.org/10.1136/bcr-2016-219160 |
work_keys_str_mv | AT anandgurpreet severehypophosphataemiaafterintravenousironadministration AT schmidchristoph severehypophosphataemiaafterintravenousironadministration |